Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diomed Holdings, Inc.
Company announces Medicare/Medicaid reimbursement for EVLT
December 7th, 2004
Diomed Holdings, Inc., (DIO), a developer and marketer of minimally invasive medical technologies, announced that the U.S. Center for Medicare and Medicaid Services (CMS) has established reimbursement codes for laser ablation as a mode of treatment for superficial vein disorders, including its patented EndoVenous Laser Treatment (EVLT) for varicose veins. The new codes, which are established by the American Medical Association and the CMS, form the basis for Medicare and Medicaid reimbursement across the U.S. and are expected to become effective January 1, 2005. Under the new codes, doctors performing the EVLT procedure in an office or clinic setting...
Source: Cardiovascular Business Week (2004-12-07)
|
